Reagensi i testovi za potrebe NGS dijagnostike nasljednih bolesti i molekularne hematologije
TED · 534328-2026Award noticeawardedNo deadline given
Value
Estimated€61,280 · 61,280 EUR
Awarded€30,639 · 30,638.51 EUR
WinnerINEL - MEDICINSKA TEHNIKA d.o.o.
Who already wins at this buyer
Firms with recorded awards from Klinički bolnički centar Zagreb in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| MEDIKA, d.d. | 7 | €13,582,629 | 2026-09-17 |
| ROCHE d.o.o. | 3 | €1,361,777 | 2026-07-08 |
| MEDICAL INTERTRADE d.o.o. | 2 | €2,338,366 | 2026-07-20 |
| KEFO d.o.o. | MEDICAL INTERTRADE d.o.o. | BIOMEDICA DIJAGNOSTIKA d.o.o. | ROCHE d.o.o. | BIOVIT d.o.o. | GOREA PLUS d.o.o. | JASIKA d.o.o. | BIOSISTEMI d.o.o. | 2 | €1,885,337 | 2026-08-17 |
| Altium International d.o.o. | BIOSISTEMI d.o.o. | 2 | €983,601 | 2026-07-07 |
Full buyer profile: what Klinički bolnički centar Zagreb buys and who wins it →
CPV codes
33696500 Medical equipment & pharmaceuticalsDescription
Reagensi i testovi za potrebe NGS dijagnostike nasljednih bolesti i molekularne hematologije
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-06 | Reagensi i testovi za potrebe NGS dijagnostike nasljednih bolesti i molekularne hematologije | Klinički bolnički centar Zagreb HR | 100% |
| 2026-07-17 | Reagensi i testovi za potrebe laboratorijske dijagnostike -11 PROTOČNI CITOMETAR | Klinički bolnički centar Zagreb HR | 94% |
| 2026-08-17 | Nabava kemikalija i specijalnih laboratorijskih reagensa | Klinički bolnički centar Zagreb HR | 93% |
| 2026-08-03 | Nabava reagensa i testova za potrebe laboratorijske dijagnostike 1A i 1B | Klinički bolnički centar Zagreb HR | 92% |
| 2026-04-30 | Nabava reagensa i potrošnog materijala za hematološki analizator za potrebe Kliničkog zavoda za laboratorijsku dijagnostiku | KB Dubrava HR | 92% |
| 2026-08-24 | Reagensi i medicinski potrošni materijal za sveobuhvatno gensko profiliranje tumora | Klinički bolnički centar Zagreb HR | 91% |